Diosynth is a leading manufacturer of bulk active pharmaceutical ingredients. Recognized reliability, broad experience, fundamental technical insight and a strong commitment to cGMP are the basis for Diosynth's operations. Contract biopharmaceutical outsourcing using modern biotechnological production methods is a cornerstone of our activities.

Diosynth Biotechnology has process development, scale-up, cGMP clinical and commercial biomanufacturing to industrial scale both in the Netherlands and the U.S. Our multi purpose upstream processing facilities comprise of microbial fermentation reactor streets with reactor volumes up to 10,000 liters and mammalian cell culture reactor volumes up to 18,000 liters. These upstream capacities are backed by a large multi purpose downstream processing facility, containing 18 purification cleanrooms.